A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2017; you can also visit the original URL.
The file type is application/pdf
.
Combination antifungal therapy for invasive aspergillosis – Is it indicated?
2006
Medical Mycology
The optimal therapy for invasive aspergillosis (IA) is unknown, and there is little agreement on the exact antifungal management of IA. The previously stagnant landscape of antifungal choices for IA is rapidly changing with newer antifungals and newer targets. While amphotericin B had historically been the preferred therapy, recent studies support voriconazole as primary therapy or caspofungin as salvage therapy. However, in vitro studies, animal models, and limited clinical reports suggest
doi:10.1080/13693780600860953
pmid:30408932
fatcat:hluryv5ok5avhfyks6umujtkbm